All Stories

  1. Prognostic impact of cancer-associated active fibroblasts and invasive architectural patterns on early-stage lung adenocarcinoma

    Article • Lung Cancer, July 2020, Elsevier

    Noriko Motoi

  2. Whole-exome and RNA sequencing of pulmonary carcinoid reveals chromosomal rearrangements associated with recurrence

    Article • Lung Cancer, July 2020, Elsevier

    Noriko Motoi

  3. Insulinoma-associated Protein 1 (INSM1) Is a Better Marker for the Diagnosis and Prognosis Estimation of Small Cell Lung Carcinoma Than Neuroendocrine Phenotype Markers Such as Chromogranin A, Synaptophysin, and CD56

    Article • The American Journal of Surgical Pathology, June 2020, Wolters Kluwer Health

    Noriko Motoi

  4. Histological and prognostic data on surgically resected early-stage lung adenocarcinoma

    Article • Data in Brief, May 2020, Elsevier

    Noriko Motoi

  5. Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites

    Article • Gynecologic Oncology, May 2020, Elsevier

    Noriko Motoi

  6. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy

    Article • Journal of Thoracic Oncology, May 2020, Elsevier

    Noriko Motoi

  7. CD20 + tumor‐infiltrating immune cells and CD204 + M2 macrophages are associated with prognosis in thymic carcinoma

    Article • Cancer Science, April 2020, Wiley

    Noriko Motoi

  8. Ciliated Muconodular Papillary Tumor of the Lung: Thin-Section CT Findings of 16 Cases

    Article • American Journal of Roentgenology, April 2020, American Roentgen Ray Society

    Noriko Motoi

  9. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee

    Article • Journal of Thoracic Oncology, April 2020, Elsevier

    Noriko Motoi

  10. Cytology Reporting System for Lung Cancer from the Japan Lung Cancer Society and Japanese Society of Clinical Cytology: An Interobserver Reproducibility Study and Risk of Malignancy Evaluation on Cytology Specimens

    Article • Acta Cytologica, March 2020, Karger Publishers

    Noriko Motoi

  11. Ciliated muconodular papillary tumor of the lung: 18F-FDG PET/CT findings of 15 cases

    Article • Annals of Nuclear Medicine, March 2020, Springer Science + Business Media

    Noriko Motoi

  12. Nivolumab for patients with metastatic uveal melanoma previously untreated with ipilimumab

    Article • Melanoma Research, February 2020, Wolters Kluwer Health

    Noriko Motoi

  13. EP1.18-03 Outcome of Surgical Resection for Invasive Mucinous Adenocarcinoma: Experience at a Single Institution

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Noriko Motoi

  14. MA08.06 Perioperative Outcomes of Lung Cancer Patients with Interstitial Pneumonia

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Noriko Motoi

  15. MA15.03 Exploring Digital Pathology-Based Morphological Biomarkers for a Better Patients’ Selection to the Immune Checkpoint Inhibitor of Lung Cancer

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Noriko Motoi

  16. P1.09-11 Influences of Sampling Method to Morphological Feature Measurement of Lung Cancer Cell

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Noriko Motoi

  17. P2.09-10 INSM1 Is a Good Marker for Diagnosis of Small Cell Lung Carcinoma Even When Neuroendocrine Marker Negative

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Noriko Motoi

  18. P2.09-24 IASLC Global Survey for Pathologists on PD-L1 Testing for Non-Small Cell Lung Cancer

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Noriko Motoi

  19. A Minimum Of 100 Tumor Cells in a Single Biopsy Sample Is Required to Assess Programmed Cell Death Ligand 1 Expression in Predicting Patient Response to Nivolumab Treatment in Nonsquamous Non–Small Cell Lung Carcinoma

    Article • Journal of Thoracic Oncology, October 2019, Elsevier

    Noriko Motoi

  20. Prognostic Impact of Tumor Doubling Time in Patients with Metachronous Lung Cancer

    Article • World Journal of Surgery, September 2019, Springer Science + Business Media

    Noriko Motoi

  21. Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report

    Article • Oxford Medical Case Reports, July 2019, Oxford University Press (OUP)

    Noriko Motoi

  22. Assessment of PD-L1 expression and oncogenic gene status in patients with small-cell lung cancer: Immuno-oncology biomarker study in LC-SCRUM-Japan.

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  23. The efficacy of immune checkpoint inhibitors and PD-L1 status in patients with advanced non-small cell lung cancer harboring oncogenic driver alterations: Immuno-oncology biomarker study in LC-SCRUM-Japan.

    Article • Journal of Clinical Oncology, May 2019, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  24. Immunocytochemistry for predictive biomarker testing in lung cancer cytology

    Article • Cancer Cytopathology, May 2019, Wiley

    Noriko Motoi

  25. Tumor expression and usefulness as a biomarker of programmed death ligand 1 in advanced non-small cell lung cancer patients with preexisting interstitial lung disease

    Article • Medical Oncology, April 2019, Springer Science + Business Media

    Noriko Motoi

  26. Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report

    Article • Thoracic Cancer, April 2019, Wiley

    Noriko Motoi

  27. Correlation between folate receptor alpha (FRα) expression and clinicopathological features in lung adenocarcinoma

    Article • Annals of Oncology, April 2019, Elsevier

    Noriko Motoi

  28. Feasibility and utility of a panel testing for 114 cancer‐associated genes in a clinical setting: A hospital‐based study

    Article • Cancer Science, April 2019, Wiley

    Noriko Motoi

  29. Cryobiopsy during flex-rigid pleuroscopy: an emerging alternative biopsy method in malignant pleural mesothelioma. A comparative study of pathology

    Article • Japanese Journal of Clinical Oncology, March 2019, Oxford University Press (OUP)

    Noriko Motoi

  30. Neuroendocrine Tumor of Lung and Mediastinum: the Updated Pathological Diagnosis and Treatment

    Article • Haigan, February 2019, Japan Lung Cancer Society

    Noriko Motoi

  31. Malignant pleural effusion as a predictor of the efficacy of anti‐PD‐1 antibody in patients with non‐small cell lung cancer

    Article • Thoracic Cancer, February 2019, Wiley

    Noriko Motoi

  32. Trimodality therapy for superior sulcus tumour: experience of a single institution over 19 years

    Article • European Journal of Cardio-Thoracic Surgery, January 2019, Oxford University Press (OUP)

    Noriko Motoi

  33. Primary pulmonary meningioma: A rare case report of aspiration cytological features and immunohistochemical assessment

    Article • Diagnostic Cytopathology, December 2018, Wiley

    Noriko Motoi

  34. Deleterious Pulmonary Surfactant System Gene Mutations in Lung Adenocarcinomas Associated With Usual Interstitial Pneumonia

    Article • JCO Precision Oncology, November 2018, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  35. Change in the lymphocyte-to-monocyte ratio is an early surrogate marker of the efficacy of nivolumab monotherapy in advanced non-small-cell lung cancer

    Article • Lung Cancer, October 2018, Elsevier

    Noriko Motoi

  36. OA03.02 Nationwide Comparative Study Of PD-L1 IHC Assays on Lung Cancer: Initial Report Of LC-SCRUM-IBIS Project

    Article • Journal of Thoracic Oncology, October 2018, Elsevier

    Noriko Motoi

  37. Immuno-oncology biomarker study in a large cohort of LC-SCRUM-Japan: LC-SCRUM-IBIS

    Article • Annals of Oncology, October 2018, Elsevier

    Noriko Motoi

  38. SMARCB-1 deficient squamous cell carcinoma of a mediastinal cyst

    Article • Pathology International, September 2018, Wiley

    Noriko Motoi

  39. Immuno-oncology biomarker study in a large cohort of LC-SCRUM-Japan: Assessment of PD-L1 expression and tumor mutation burden in non-small cell lung cancer patients treated with immune checkpoint inhibitors.

    Article • Journal of Clinical Oncology, May 2018, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  40. Clinical Features of Ground Glass Opacity–Dominant Lung Cancer Exceeding 3.0 cm in the Whole Tumor Size

    Article • The Annals of Thoracic Surgery, May 2018, Elsevier

    Noriko Motoi

  41. An Update of Companion Diagnostics for Lung Cancer

    Article • Haigan, April 2018, Japan Lung Cancer Society

    Noriko Motoi

  42. Response to Letter to the Editor Titled “Comments on Prognostic Impact of Margin Distance and Tumor Spread through Air Spaces in Limited Resection for Primary Lung Cancer”

    Article • Journal of Thoracic Oncology, April 2018, Elsevier

    Noriko Motoi

  43. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene

    Article • Pathology - Research and Practice, February 2018, Elsevier

    Noriko Motoi

  44. Stromal tiny black dots, like “sugar-coated”, of von Kossa stain is a diagnostic clue to hyalinizing trabecular tumor of the thyroid gland

    Article • Pathology International, January 2018, Wiley

    CT Miyako Higuchi, Noriko Motoi

  45. A case of myoepithelial carcinoma of the left shoulder

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2018, The Japanese Society of Clinical Cytology

    Noriko Motoi

  46. Prognostic Impact of Margin Distance and Tumor Spread Through Air Spaces in Limited Resection for Primary Lung Cancer

    Article • Journal of Thoracic Oncology, December 2017, Elsevier

    Noriko Motoi

  47. Programmed Death-Ligand 1 Immunohistochemistry Testing: A Review of Analytical Assays and Clinical Implementation in Non–Small-Cell Lung Cancer

    Article • Journal of Clinical Oncology, December 2017, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  48. P1.02-009 Accumulation of Mutations in Background Normal Lung Tissue Constitutes a Major Lung Cancer Risk

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Noriko Motoi

  49. P1.05-002 Characteristics and Prognosis of Ground Glass Opacity Predominant Primary Lung Cancer Larger Than 3.0 Cm on Thin-Section Computed Tomography

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Noriko Motoi

  50. P2.02-035 PD-L1 IHC Test on Cytological Cell Block Specimen; Potential Utility and Practical Issues

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Noriko Motoi

  51. P3.02-035 Mutational Signatures and Their Association with Clinicopathological Features in Lung Adenocarcinoma of Smokers

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Noriko Motoi

  52. P3.02-041 EGFR Amplification Mediates Resistance to TAS121, A Third-Generation EGFR-TKI, in EGFR T790M-Positive Non-Small Cell Lung Cancer

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Noriko Motoi

  53. P3.13-009 Rapid Detection of Lung Cancer by Fluorescent Imaging Using A γ-Glutamyltranspeptidase-Activatable Fluorescent Probe

    Article • Journal of Thoracic Oncology, November 2017, Elsevier

    Noriko Motoi

  54. Actinin-4 protein overexpression as a predictive biomarker in adjuvant chemotherapy for resected lung adenocarcinoma

    Article • Biomarkers in Medicine, September 2017, Future Medicine

    Noriko Motoi

  55. A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size

    Article • The Annals of Thoracic Surgery, September 2017, Elsevier

    Noriko Motoi

  56. EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer

    Article • Clinical Lung Cancer, September 2017, Elsevier

    Noriko Motoi

  57. The new transbronchial diagnostic approach for the metastatic lung tumor from renal cell carcinoma—a case report

    Article • Journal of Thoracic Disease, September 2017, AME Publishing Company

    Noriko Motoi

  58. Stromal infiltrating CD8+ and CD20+ lymphocytes and CD204+ M2 macrophages but not PD-L1 expression on tumor cells are prognosticators for patients with resectable thymic carcinoma.

    Article • Journal of Clinical Oncology, May 2017, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  59. Clinicopathological and molecular characterization of SMARCA4-deficient thoracic sarcomas with comparison to potentially related entities

    Article • Modern Pathology, March 2017, Springer Science + Business Media

    Noriko Motoi

  60. Prognostic value of CD8+ tumor-infiltrating lymphocyte density and PD-L1 expression in tumor cells in thymic epithelial tumors.

    Article • Journal of Clinical Oncology, March 2017, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  61. Pulmonary Carcinoids and Low-Grade Gastrointestinal Neuroendocrine Tumors Show Common MicroRNA Expression Profiles, Different from Adenocarcinomas and Small Cell Carcinomas

    Article • Neuroendocrinology, February 2017, Karger Publishers

    Noriko Motoi

  62. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases

    Article • Journal of Thoracic Oncology, February 2017, Elsevier

    Noriko Motoi

  63. P3.01-006 Prognostic Impact of Tumor Spread through Air Spaces in Limited Resection for pStage I Lung Cancer

    Article • Journal of Thoracic Oncology, January 2017, Elsevier

    Noriko Motoi

  64. P3.01-015 Prognostic Impact of Histologic Invasion Factors in Pulmonary Adenocarcinoma, with Particular Focus on the Pattern of Architectural Remodeling

    Article • Journal of Thoracic Oncology, January 2017, Elsevier

    Noriko Motoi

  65. P3.02c-097 Nivolumab in Elderly or Poor Performance Status Patients with Advanced Non-Small Cell Lung Cancer

    Article • Journal of Thoracic Oncology, January 2017, Elsevier

    Noriko Motoi

  66. PUB015 The Use of Immunohistochemistry Improves the Diagnosis of SCLC. An International Reproducibility Study in a Demanding Set of Cases

    Article • Journal of Thoracic Oncology, January 2017, Elsevier

    Noriko Motoi

  67. Two-stage surgery on pregnant woman with a giant cell tumor of bone who refused blood transfusion: A case report

    Article • Journal of Orthopaedic Science, January 2017, Elsevier

    Noriko Motoi

  68. PD-L1 IHC expression status in Japanese lung adenocarcinoma

    Article • Pathology International, December 2016, Wiley

    Noriko Motoi

  69. Clinicopathological, Immunohistochemical, and Genetic Features of Primary Lung Adenocarcinoma Occurring in the Setting of Usual Interstitial Pneumonia Pattern

    Article • Journal of Thoracic Oncology, December 2016, Elsevier

    Noriko Motoi

  70. A newly emerged osteosarcomatous dedifferentiation of liposarcoma in lung metastasis - a potential diagnostic pitfall

    Article • Pathology International, November 2016, Wiley

    Noriko Motoi

  71. Giant lamellar bodies associated with adenocarcinoma of the lung

    Article • Histopathology, September 2016, Wiley

    Noriko Motoi

  72. Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: a single-institute analysis

    Article • BMC Cancer, September 2016, Springer Science + Business Media

    Noriko Motoi

  73. Touch cytology smear of an inflammatory hepatocellular adenoma displaying an unusual pattern: A case report

    Article • Diagnostic Cytopathology, July 2016, Wiley

    Noriko Motoi

  74. Abstract 3542: Abnormal intracytoplasmic accumulation of autophagy-related protein p62/SQSTM1 characterizes giant cells of giant cell tumor of bone

    Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

    Ikuma Kato, Noriko Motoi

  75. Risk factors for distant metastasis of dermatofibrosarcoma protuberans

    Article • Journal of Orthopaedics and Traumatology, June 2016, Springer Science + Business Media

    Noriko Motoi

  76. Feasibility of EBUS-TBNA specimens for PD-L1 expression test in lung cancer.

    Article • Journal of Clinical Oncology, May 2016, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  77. Therapeutic value of lymph node dissection for right middle lobe non-small-cell lung cancer

    Article • Journal of Thoracic Disease, May 2016, AME Publishing Company

    Noriko Motoi

  78. Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer

    Article • Lung Cancer, March 2016, Elsevier

    Noriko Motoi

  79. Prognostic significance of CpG island methylator phenotype in surgically resected small cell lung carcinoma

    Article • Cancer Science, February 2016, Wiley

    Noriko Motoi

  80. P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

    Article • EBioMedicine, January 2016, Elsevier

    Noriko Motoi

  81. Resection of a large ectopic parathyroid adenoma: A case report

    Article • International Journal of Surgery Case Reports, January 2016, Elsevier

    Noriko Motoi

  82. Imprint cytology of pulmonary artery sarcoma

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2016, The Japanese Society of Clinical Cytology

    Noriko Motoi

  83. Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin

    Article • Medicine, December 2015, Wolters Kluwer Health

    Dr Yuichi Ishikawa, Noriko Motoi

  84. Rapidly growing giant cell tumor of bone in a skeletally immature girl

    Article • Skeletal Radiology, November 2015, Springer Science + Business Media

    Noriko Motoi

  85. A case of inflammatory hepatocellular adenoma displaying an unusual histological pattern

    Article • Clinical Journal of Gastroenterology, November 2015, Springer Science + Business Media

    Noriko Motoi

  86. Pulmonary artery sarcoma presenting as an isolated lung mass

    Article • General Thoracic and Cardiovascular Surgery, November 2015, Springer Science + Business Media

    Noriko Motoi

  87. Cancer emerging from the recurrence of sessile serrated adenoma/polyp resected endoscopically 5 years ago

    Article • Japanese Journal of Clinical Oncology, November 2015, Oxford University Press (OUP)

    Noriko Motoi

  88. Prognostic impact of bulky swollen lymph nodes in cN1 non-small cell lung cancer patients

    Article • Japanese Journal of Clinical Oncology, September 2015, Oxford University Press (OUP)

    Noriko Motoi

  89. Lymph Node Metastases and Prognosis in Left Upper Division Non-Small Cell Lung Cancers: The Impact of Interlobar Lymph Node Metastasis

    Article • PLoS ONE, August 2015, PLOS

    Noriko Motoi

  90. Pulmonary Adenocarcinoma In Situ

    Article • The American Journal of Surgical Pathology, July 2015, Wolters Kluwer Health

    Noriko Motoi

  91. Risk factors of pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment.

    Article • Journal of Clinical Oncology, May 2015, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  92. Differences in the responses to pazopanib and the prognoses of soft tissue sarcomas by their histological eligibility for the PALETTE study

    Article • Japanese Journal of Clinical Oncology, February 2015, Oxford University Press (OUP)

    Noriko Motoi

  93. The CYVADIC Regimen as a Combination Chemotherapy Treatment Option for Advanced Soft Tissue Sarcomas Originating from the Non-Extremities

    Article • Internal Medicine, January 2015, Japanese Society of Internal Medicine

    Noriko Motoi

  94. Intrathyroidal Epithelial Thymoma: Carcinoma Showing Thymus-like Differentiation Mimicking Squamous Cell Carcinoma of the Thyroid

    Article • Journal of Nippon Medical School, January 2015, Medical Association of Nippon Medical School

    Noriko Motoi

  95. A Clinicopathological Analysis of Soft Tissue Sarcoma with Telangiectatic Changes

    Article • Sarcoma, January 2015, Hindawi Publishing Corporation

    Noriko Motoi

  96. Case Report: Asymptomatic Osteosarcoma

    Article • Case Reports in Clinical Medicine, January 2015, Scientific Research Publishing, Inc,

    Noriko Motoi

  97. Cytogenetic study of secondary malignancy in giant cell tumor

    Article • Journal of Orthopaedic Science, January 2015, Elsevier

    Noriko Motoi

  98. Cytological evaluation of thyroid cyst

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2015, The Japanese Society of Clinical Cytology

    Noriko Motoi

  99. Ultrasonographic and non-enhanced CT features of acute transient thyroid swelling following fine-needle aspiration biopsy: report of four cases

    Article • Journal of Medical Ultrasonics, December 2014, Springer Science + Business Media

    Noriko Motoi

  100. Prognostic Significance of Tumor Size of Small Lung Adenocarcinomas Evaluated with Mediastinal Window Settings on Computed Tomography

    Article • PLoS ONE, November 2014, PLOS

    Noriko Motoi

  101. A Novel Mechanism of EML4-ALK Rearrangement Mediated by Chromothripsis in a Patient-Derived Cell Line

    Article • Journal of Thoracic Oncology, November 2014, Elsevier

    Noriko Motoi

  102. Salivary gland-type neoplasm of the lung

    Article • Diagnostic Histopathology, October 2014, Elsevier

    Noriko Motoi

  103. Hepatoid tenosynovial giant cell tumor – A rare morphologic variant case report

    Article • Pathology - Research and Practice, October 2014, Elsevier

    Noriko Motoi

  104. Abstract 300: Expression profiling of miRNA in asbestos-related lung adenocarcinoma

    Article • September 2014, American Association for Cancer Research (AACR)

    Noriko Motoi

  105. Incidence of Pneumothorax in Advanced and/or Metastatic Soft Tissue Sarcoma Patients during Pazopanib Treatment

    Article • Clinical Oncology, June 2014, Elsevier

    Noriko Motoi

  106. A subset of small cell lung cancer with low neuroendocrine expression and good prognosis: a comparison study of surgical and inoperable cases with biopsy

    Article • Human Pathology, May 2014, Elsevier

    Noriko Motoi

  107. Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease

    Article • The American Journal of Surgical Pathology, April 2014, Wolters Kluwer Health

    Noriko Motoi

  108. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small‐cell lung cancer

    Article • Cancer Medicine, March 2014, Wiley

    Dr Yuichi Ishikawa, Noriko Motoi

  109. Early evaluation of the therapeutic effect of denosumab on tartrate-resistant acid phosphatase 5b expression in a giant cell tumor of bone: a case report

    Article • BMC Research Notes, January 2014, Springer Science + Business Media

    Noriko Motoi

  110. Two Cases of Synchronous Multiple Lung Cancer Harboring Different Mutations; EGFR or ALK

    Article • Haigan, January 2014, Japan Lung Cancer Society

    Noriko Motoi

  111. Cytological evaluation of the ^|^ldquo;Indeterminate^|^rdquo; category by The Bethesda System for Reporting Thyroid Cytopathology

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2014, The Japanese Society of Clinical Cytology

    Noriko Motoi

  112. Presumptive diagnosis of pulmonary PEComa by imprint cytology^|^mdash;A case report^|^mdash;

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2014, The Japanese Society of Clinical Cytology

    Noriko Motoi

  113. Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes

    Article • BMC Cancer, January 2013, Springer Science + Business Media

    Noriko Motoi

  114. A case of inflammatory myofibroblastic tumor diagnosed by thoracoscopic resection : A case report

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2013, The Japanese Society of Clinical Cytology

    Noriko Motoi

  115. Cytopathological review of patients that underwent thyroidectomies based on the diagnosis of papillary thyroid carcinoma by fine needle aspiration cytology but were later found to have benign tumors by histopathology

    Article • Surgery Today, October 2012, Springer Science + Business Media

    Noriko Motoi

  116. Sonographic findings in three cases of carcinoma showing thymus-like differentiation

    Article • Journal of Clinical Ultrasound, October 2012, Wiley

    Noriko Motoi

  117. Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma. An international interobserver study

    Article • Modern Pathology, July 2012, Springer Science + Business Media

    Noriko Motoi

  118. ALK and EGFR mutation analysis in a phase II trial of cisplatin/pemetrexed in Japanese patients with advanced nonsquamous non-small cell lung cancer.

    Article • Journal of Clinical Oncology, May 2012, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  119. Bronchial granular cell tumor^|^mdash;a report of two cases^|^mdash;

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2012, The Japanese Society of Clinical Cytology

    Noriko Motoi

  120. Clinicopathological findings of non-small-cell lung cancer with high serum progastrin-releasing peptide concentrations

    Article • Lung Cancer, December 2011, Elsevier

    Noriko Motoi

  121. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases

    Article • Modern Pathology, January 2011, Springer Science + Business Media

    Noriko Motoi

  122. A Case of Concurrent Sarcoidosis, Aortitis Syndrome and Crohn's Disease

    Article • Internal Medicine, January 2011, Japanese Society of Internal Medicine

    Noriko Motoi

  123. Malignant pleural mesothelioma showing a solitary shadow in the lung field-A case report-

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2011, The Japanese Society of Clinical Cytology

    Noriko Motoi

  124. Intrinsic Cooperation between p16INK4a and p21Waf1/Cip1 in the Onset of Cellular Senescence and Tumor Suppression In vivo

    Article • Cancer Research, November 2010, American Association for Cancer Research (AACR)

    Noriko Motoi

  125. Cytokeratin expression profiling is useful for distinguishing between primary squamous cell carcinoma of the lung and pulmonary metastases from tongue cancer

    Article • Pathology International, July 2010, Wiley

    Noriko Motoi

  126. Immunohistochemical screening of ALK lung cancer with biopsy specimens of advanced lung cancer.

    Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  127. Identification of DOK genes as lung tumor suppressors

    Article • Nature Genetics, February 2010, Springer Science + Business Media

    Noriko Motoi

  128. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors

    Article • Oncogene, June 2009, Springer Science + Business Media

    Noriko Motoi

  129. EML4-ALK lung cancers are characterized by rare other mutations, a TTF-1 cell lineage, an acinar histology, and young onset

    Article • Modern Pathology, February 2009, Springer Science + Business Media

    Noriko Motoi

  130. Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

    Article • Nature Medicine, July 2008, Springer Science + Business Media

    Noriko Motoi

  131. Lung Adenocarcinoma: Modification of the 2004 WHO Mixed Subtype to Include the Major Histologic Subtype Suggests Correlations Between Papillary and Micropapillary Adenocarcinoma Subtypes, EGFR Mutations and Gene Expression Analysis

    Article • The American Journal of Surgical Pathology, June 2008, Wolters Kluwer Health

    Noriko Motoi

  132. MET amplification occurs with or without T790M mutations in EGFR mutant lung tumors with acquired resistance to gefitinib or erlotinib

    Article • Proceedings of the National Academy of Sciences, December 2007, Proceedings of the National Academy of Sciences

    Noriko Motoi

  133. Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

    Article • Journal of Clinical Investigation, December 2007, American Society for Clinical Investigation

    Noriko Motoi

  134. PD1-3-6: Gene expession prolifing of large cell neuroendocrine carcinoma (LCNEC)

    Article • Journal of Thoracic Oncology, August 2007, Elsevier

    Noriko Motoi

  135. Integrated genomic analysis of lung adenocarcinomas identifies loss of the MAPK phosphatase gene DUSP4 in most EGFR mutant tumors

    Article • Journal of Clinical Oncology, June 2007, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  136. Multiple bronchioloalveolar carcinomas in acromegaly: A potential role of insulin-like growth factor I in carcinogenesis

    Article • Lung Cancer, November 2006, Elsevier

    Noriko Motoi

  137. Genital β2-Microglobulin Amyloidoma in a Long-Term Dialysis Patient

    Article • American Journal of Kidney Diseases, September 2006, Elsevier

    Noriko Motoi

  138. Mycosis Fungoides in a Hemodialysis Patient With Intractable Pruritus

    Article • Therapeutic Apheresis and Dialysis, June 2006, Wiley

    Noriko Motoi

  139. Clinical features and high-resolution CT findings of pulmonary cryptococcosis in non-AIDS patients

    Article • Respiratory Medicine, May 2006, Elsevier

    Noriko Motoi

  140. Comparative Clinicopathology of Obliterative Bronchiolitis and Diffuse Panbronchiolitis

    Article • Respiration, January 2006, Karger Publishers

    Noriko Motoi

  141. High-Resolution Computed Tomography Findings of Lung Cancer Associated With Idiopathic Pulmonary Fibrosis

    Article • Journal of Computer Assisted Tomography, January 2006, Wolters Kluwer Health

    Noriko Motoi

  142. A Case of Malignant Pleural Mesothelioma Mimicking Bronchioloalveolar Carcinoma in Its Intrapulmonary Growth Pattern

    Article • Haigan, January 2006, Japan Lung Cancer Society

    Noriko Motoi

  143. Pigmented neurofibroma: review of Japanese patients with an analysis of melanogenesis demonstrating coexpression of c-met protooncogene and microphthalmia-associated transcription factor

    Article • Human Pathology, August 2005, Elsevier

    Noriko Motoi

  144. Malignant T-cell lymphoma of the thyroid gland associated with Hashimoto's thyroiditis

    Article • Pathology International, July 2005, Wiley

    Noriko Motoi

  145. Factors predicting the efficacy of gefitinib in patients with advanced non-small cell lung cancer (NSCLC)

    Article • Journal of Clinical Oncology, June 2005, American Society of Clinical Oncology (ASCO)

    Noriko Motoi

  146. Cyclosporin Treatment in Steroid-resistant and Acutely Exacerbated Interstitial Pneumonia

    Article • Internal Medicine, January 2005, Japanese Society of Internal Medicine

    Noriko Motoi

  147. Rounded Atelectasis Associated with Pulmonary Lymphangioleiomyomatosis

    Article • Internal Medicine, January 2005, Japanese Society of Internal Medicine

    Noriko Motoi

  148. A Case of Sjögren's Syndrome with Wegener's Granulomatosis-like Pulmonary Involvement

    Article • Allergology International, January 2005, Japanese Society of Allergology

    Noriko Motoi

  149. Pulmonary fibrosis in an individual occupationally exposed to inhaled indium-tin oxide

    Article • European Respiratory Journal, January 2005, European Respiratory Society (ERS)

    Noriko Motoi

  150. Small lung tumors with the size of 1cm or less in diameter: clinical, radiological, and histopathological characteristics

    Article • Lung Cancer, April 2004, Elsevier

    Noriko Motoi

  151. Spindle cell lipoma of the knee: a case report

    Article • Journal of Orthopaedic Science, January 2004, Elsevier

    Noriko Motoi

  152. Acinar Cell Carcinoma of the Pancreas with Intraductal Growth: Report of a Case

    Article • Pancreas, April 2003, Wolters Kluwer Health

    Noriko Motoi

  153. Chondrosarcoma of the hand secondary to multiple enchondromatosis; report of two cases

    Article • Archives of Orthopaedic and Traumatic Surgery, February 2003, Springer Science + Business Media

    Noriko Motoi

  154. Intracortical chondroblastoma mimicking intra-articular osteoid osteoma

    Article • Skeletal Radiology, October 2002, Springer Science + Business Media

    Noriko Motoi

  155. Primary leiomyosarcoma of the femur

    Article • Journal of Orthopaedic Science, March 2002, Elsevier

    Noriko Motoi

  156. Bilateral choroidal metastases secondary to uterocervical carcinoma of the squamous cell type

    Article • American Journal of Ophthalmology, November 2000, Elsevier

    Noriko Motoi

  157. Role of ras mutation in the progression of thyroid carcinoma of follicular epithelial origin

    Article • Pathology - Research and Practice, January 2000, Elsevier

    Noriko Motoi

  158. A Case of Retained Surgical Sponge (gossypiboma) and MR Features.

    Article • The Japanese Journal of Gastroenterological Surgery, January 2000, The Japanese Journal of Gastroenterological Surgery

    Noriko Motoi

  159. Cytology of tuberculous endometritis - Report of a case.

    Article • The Journal of the Japanese Society of Clinical Cytology, January 2000, The Japanese Society of Clinical Cytology

    Noriko Motoi

  160. Dedifferentiated chondrosarcoma of the rib with a malignant mesenchymomatous component: An autopsy case report

    Article • Pathology International, June 1997, Wiley

    Noriko Motoi

  161. Necrotizing Bacillus cereus infection of the meninges without inflammatory reaction in a patient with acute myelogenous leukemia: a case report

    Article • Acta Neuropathologica, March 1997, Springer Science + Business Media

    Noriko Motoi

  162. Cytological study of six cases of synovial sarcoma.

    Article • The Journal of the Japanese Society of Clinical Cytology, January 1997, The Japanese Society of Clinical Cytology

    Noriko Motoi

  163. Epithelioid sarcoma cytologic features of two cases.

    Article • The Journal of the Japanese Society of Clinical Cytology, January 1997, The Japanese Society of Clinical Cytology

    Noriko Motoi

  164. Fulminant Septicemic Syndrome of Bacillus cereus in a Leukemic Patient.

    Article • Internal Medicine, January 1997, Japanese Society of Internal Medicine

    Noriko Motoi

  165. A case of subependymoma of the lateral ventricle. Cytological features.

    Article • The Journal of the Japanese Society of Clinical Cytology, January 1997, The Japanese Society of Clinical Cytology

    Noriko Motoi

  166. Neuroendocrine Tumors of the Liver and Pancreas Associated with Elevated Serum Prostatic Acid Phosphatase.

    Article • Internal Medicine, January 1995, Japanese Society of Internal Medicine

    Noriko Motoi